Paper2007355
Use of omeprazole in patients with Zollinger-Ellison syndrome.
Frucht H and 2 others. Dig Dis Sci, 1991. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Use of omeprazole in patients with Zollinger-Ellison syndrome. Papers, record 2007355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2007355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Omeprazole | Major topic |
| Zollinger-Ellison Syndrome | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 1354155 | Zollinger-Ellison syndrome, antisecretory treatment, and body weight. | https://conductscience.org/library/papers/1354155 |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3335308 | Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. | Gastroenterology | 1988 | https://conductscience.org/library/papers/3335308 | PubMed |
| 2 | 2293597 | Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. | Gastroenterology | 1990 | https://conductscience.org/library/papers/2293597 | PubMed |
| 3 | 3972233 | Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. | Gastroenterology | 1985 | https://conductscience.org/library/papers/3972233 | PubMed |
| 4 | 6705649 | Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome. | Dig Dis Sci | 1984 | https://conductscience.org/library/papers/6705649 | PubMed |
| 5 | 3072229 | Histopathological classification of nonantral gastric endocrine growths in man. | Digestion | 1988 | https://conductscience.org/library/papers/3072229 | PubMed |
| 6 | 6336642 | Zollinger-Ellison syndrome: current concepts and management. | Ann Intern Med | 1983 | https://conductscience.org/library/papers/6336642 | PubMed |
| 7 | 2564577 | Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole. | Lancet | 1989 | https://conductscience.org/library/papers/2564577 | PubMed |
| 8 | 3858978 | Pharmacokinetics and metabolism of omeprazole in animals and man--an overview. | Scand J Gastroenterol Suppl | 1985 | https://conductscience.org/library/papers/3858978 | PubMed |
| 9 | 6150641 | Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. | Am J Med | 1984 | https://conductscience.org/library/papers/6150641 | PubMed |
| 10 | 6128284 | Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. | Gastroenterology | 1983 | https://conductscience.org/library/papers/6128284 | PubMed |
| 11 | 6835285 | Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6835285 | PubMed |
| 12 | 2857672 | Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. | Gastroenterology | 1985 | https://conductscience.org/library/papers/2857672 | PubMed |
| 13 | 6150883 | Assessing the safety of drugs for the long-term treatment of peptic ulcers. | Gut | 1984 | https://conductscience.org/library/papers/6150883 | PubMed |
| 14 | 2873001 | Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/2873001 | PubMed |
| 15 | 6838707 | Pathology of endocrine cells in gastric mucosa. | Ann Pathol | 1983 | https://conductscience.org/library/papers/6838707 | PubMed |
| 16 | 6259537 | Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. | Nature | 1981 | https://conductscience.org/library/papers/6259537 | PubMed |
| 17 | 3858976 | Toxicological studies on omeprazole. | Scand J Gastroenterol Suppl | 1985 | https://conductscience.org/library/papers/3858976 | PubMed |
| 18 | 3510144 | Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. | Gastroenterology | 1986 | https://conductscience.org/library/papers/3510144 | PubMed |
| 19 | 6847279 | The role of surgery in the Zollinger-Ellison syndrome. | Ann Surg | 1983 | https://conductscience.org/library/papers/6847279 | PubMed |
| 20 | 2578420 | Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. | Gastroenterology | 1985 | https://conductscience.org/library/papers/2578420 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41463062 | Current Medical Controversies in Zollinger-Ellison Syndrome. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463062 | PubMed |
| 36900170 | Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900170 | PubMed |
| 33184472 | Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma. | Oncogene | 2021 | https://conductscience.org/library/papers/33184472 | PubMed |
| 30536424 | Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective. | J Bone Miner Res | 2019 | https://conductscience.org/library/papers/30536424 | PubMed |
| 27932981 | Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/27932981 | PubMed |
| 23645327 | Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. | Medicine (Baltimore) | 2013 | https://conductscience.org/library/papers/23645327 | PubMed |
| 23363383 | Pharmacotherapy of Zollinger-Ellison syndrome. | Expert Opin Pharmacother | 2013 | https://conductscience.org/library/papers/23363383 | PubMed |
| 22740984 | Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumors. | Oncol Lett | 2012 | https://conductscience.org/library/papers/22740984 | PubMed |
| 21672194 | Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. | J Hematol Oncol | 2011 | https://conductscience.org/library/papers/21672194 | PubMed |
| 21629657 | Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. | PLoS One | 2011 | https://conductscience.org/library/papers/21629657 | PubMed |
| 17985097 | Medical treatment of gastrinomas. | Wien Klin Wochenschr | 2007 | https://conductscience.org/library/papers/17985097 | PubMed |
| 16423003 | Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. | Aliment Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16423003 | PubMed |
| 14651442 | Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients. | Drugs Aging | 2003 | https://conductscience.org/library/papers/14651442 | PubMed |
| 12924666 | Primary hepatic gastrinoma. | Dig Dis Sci | 2003 | https://conductscience.org/library/papers/12924666 | PubMed |
| 11097720 | Zollinger-Ellison Syndrome. | Curr Treat Options Gastroenterol | 1999 | https://conductscience.org/library/papers/11097720 | PubMed |
| 10980995 | The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach. | Curr Gastroenterol Rep | 1999 | https://conductscience.org/library/papers/10980995 | PubMed |
| 10734021 | Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10734021 | PubMed |
| 8799683 | Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion. | Drugs | 1996 | https://conductscience.org/library/papers/8799683 | PubMed |
| 8425437 | Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8425437 | PubMed |
| 8364130 | Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection. | Aliment Pharmacol Ther | 1993 | https://conductscience.org/library/papers/8364130 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GAST | 2520 | PubTator's text mining | https://conductscience.org/library/genes/2520 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2007355
GET https://conductscience.org/api/papers/v1/2007355/references?page=2